Head-to-head · WeighScore
RxSpan MD vs VivioMD
The verdict
RxSpan MD takes it — 84.3/100 to 57.4/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD offers compounded injections, oral options and a brand-name lane, with regular monthly pricing alongside discounted prepaid plans that require a closer look at renewal and refund terms.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | RxSpan MD | VivioMD |
|---|---|---|
| WeighScore | 84.3/100 | 57.4/100 |
| Grade | B | C |
| Site position | #6 | #450 |
| Semaglutide | $249/mo month-to-month ($219 on three months, $199 on six, $194 on twelve) | GLP-1 injection advertised from $299/mo; confirm formulation |
| Tirzepatide | $329/mo month-to-month ($309 on three months, $289 on six, $269 on twelve) | GLP-1+GIP injection advertised from $398/mo; confirm formulation |
| Coverage | Confirm treatment availability during intake | Terms exclude Louisiana; homepage says all 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #6 · B
Strengths
- Public catalog offers compounded injections, oral options and brand-name programs
- Regular monthly injection pricing of $249 semaglutide and $329 tirzepatide
- Catalog states consultation, medication, supplies, shipping and support are included
- Names physician founder Dr. John Diaz and describes licensed-physician review
Where it loses points
- Lowest advertised monthly equivalents require prepaid terms and a promotional code
- Annual promotions automatically renew
- Public terms do not establish a refund schedule for unused prepaid treatment
- Compounded semaglutide and tirzepatide are not FDA-approved
Site position #450 · C
FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.
Strengths
- Advertises GLP-1 tablets and injections plus branded Ozempic
- Terms identify OpenLoop clinical groups and RedRock, Health Warehouse and Triad Rx pharmacies
- Refund policy describes refunds for unused prepaid months without medication shipments
Where it loses points
- Terms exclude Louisiana despite nationwide homepage language
- Cancellation requests must arrive at least 72 hours before the next bill
- Headline GLP-1 product names do not specify the exact compounded formulation
- Compounded medications are not FDA-approved
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD offers compounded injections, oral options and a brand-name lane, with regular monthly pricing alongside discounted prepaid plans that require a closer look at renewal and refund terms.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.